|
1
|
Kumar AB and Suneja M: Cardiopulmonary
bypass-associated acute kidney injury. Anesthesiology. 114:964–970.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Uchino S, Bellomo R, Goldsmith D, Bates S
and Ronco S: An assessment of the RIFLE criteria for acute renal
failure in hospitalized patients. Crit Care Med. 34:1913–1917.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang Y, Lang XB, Zhang P, Lv R, Wang YF
and Chen JH: Remote ischemic preconditioning for prevention of
acute kidney injury: A meta-analysis of randomized controlled
trials. Am J Kidney Dis. 64:574–583. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang L, Zhang JY, Zhong XF, Zhu D and Liu
B: Exploration of renal microcirculation perfusion during
cardiopulmonary bypass with contrast-enhanced ultrasound. Sichuan
Da Xue Xue Bao Yi Xue Ban. 46:846–850. 2015.(In Chinese).
PubMed/NCBI
|
|
5
|
Zhong XF, Zhu D, Lu Q, Liu B and Peng YL:
Monitoring renal microcirculation perfusion alteration with
contrast-enhanced ultrasound during cardiopulmonary bypass. J
Sichuan Univ Med Sci Edi. 44:646–650. 2013.
|
|
6
|
Goldberg R and Dennen P: Long-term
outcomes of acute kidney injury. Adv Chronic Kidney Dis.
15:297–307. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Leonard EC, Friedrich JL and Basile DP:
VEGF-121 preserves renal microvessel structure and ameliorates
secondary renal disease following acute kidney injury. Am J Physiol
Renal Physiol. 295:F1648–F1657. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Masuda Y, Shimizu A, Mori T, Ishiwata T,
Kitamura H, Ohashi R, Ishizaki M, Asano G, Sugisaki Y and Yamanaka
N: Vascular endothelial growth factor enhances glomerular capillary
repair and accelerates resolution of experimentally induced
glomerulonephritis. Am J Pathol. 159:599–608. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fadel FI, Abdel Rahman AM, Mohamed MF,
Habib SA, Ibrahim MH, Sleem ZS, Bazaraa HM and Soliman MM: Plasma
neutrophil gelatinase-associated lipocalin as an early biomarker
for prediction of acute kidney injury after cardio-pulmonary bypass
in pediatric cardiac surgery. Arch Med Sci. 8:250–255. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Badylak SF, Kern KB, Tacker WA, Ewy GA,
Janas W and Carter A: The comparative pathology of open chest vs.
mechanical closed chest cardiopulmonary resuscitation in dogs.
Resuscitation. 13:249–264. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gessner R and Dayton PA: Advances in
molecular imaging with ultrasound. Mol Imaging. 9:117–127.
2010.PubMed/NCBI
|
|
12
|
Andersson LG, Bratteby LE, Ekroth R,
Hallhagen S, Joachimsson PO, van der Linden J and Wesslén O: Renal
function during cardiopulmonary bypass: Influence of pump flow and
systemic blood pressure. Eur J Cardiothorac Surg. 8:597–602. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pathi VL, Morrison J, MacPhaden A, Martin
W, McQuiston AM and Wheatley DJ: Alterations in renal
microcirculation during cardiopulmonary bypass. Ann Thorac Surg.
65:993–998. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chade AR and Kelsen S: Renal microvascular
disease determines the responses to revascularization in
experimental renovascular disease. Circ Cardiovasc Interv.
3:376–383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chade AR, Krier JD, Textor SC, Lerman A
and Lerman LO: Endothelin-a receptor blockade improves renal
microvascular architecture and function in experimental
hypercholesterolemia. J Am Soc Nephrol. 17:3394–3403. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Iliescu R, Fernandez SR, Kelsen S, Maric C
and Chade AR: Role of renal microcirculation in experimental
renovascular disease. Nephrol Dial Transplant. 25:1079–1087. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chade AR and Kelsen S: Reversal of renal
dysfunction by targeted administration of VEGF into the stenotic
kidney: A novel potential therapeutic approach. Am J Physiol Renal
Physiol. 302:F1342–F1350. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Amadio M, Govoni S and Pascale A:
Targeting VEGF in eye neovascularization: What's new?: A
comprehensive review on current therapies and oligonucleotide-based
interventions under development. Pharmacol Res. 103:253–269. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Foster RR, Armstrong L, Baker S, Wong DW,
Wylie EC, Ramnath R, Jenkins R, Singh A, Steadman R, Welsh GI, et
al: Glycosaminoglycan regulation by VEGFA and VEGFC of the
glomerular microvascular endothelial cell glycocalyx in vitro. Am J
Pathol. 183:604–616. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Iruela-Arispe L, Gordon K, Hugo C,
Duijvestijn AM, Claffey KP, Reilly M, Couser WG, Alpers CE and
Johnson RJ: Participation of glomerular endothelial cells in the
capillary repair of glomerulonephritis. Am J Pathol. 147:1715–1727.
1995.PubMed/NCBI
|
|
21
|
Logue OC, McGowan JW, George EM and
Bidwell GL III: Therapeutic angiogenesis by vascular endothelial
growth factor supplementation for treatment of renal disease. Curr
Opin Nephrol Hypertens. 25:404–409. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Larrivee B and Karsan A: Signaling
pathways induced by vascular endothelial growth factor (Review).
Int J Mol Med. 5:447–456. 2000.PubMed/NCBI
|
|
23
|
Hicklin DJ and Ellis LM: Role of the
vascular endothelial growth factor pathway in tumor growth and
angiogenesis. J Clin Oncol. 23:1011–1027. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee YM, Jeong CH, Koo SY, Son MJ, Song HS,
Bae SK, Raleigh JA, Chung HY, Yoo M and Kim KW: Determination of
hypoxic region by hypoxia marker in developing mouse embryos in
vivo: A possible signal for vessel development. Dev Dyn.
220:175–186. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vadlapatla RK, Vadlapudi AD and Mitra AK:
Hypoxia-inducible factor-1 (HIF-1): A potential target for
intervention in ocular neovascular diseases. Curr Drug Targets.
14:919–935. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Blanes MG, Oubaha M, Rautureau Y and
Gratton JP: Phosphorylation of tyrosine 801 of vascular endothelial
growth factor receptor-2 is necessary for Akt-dependent endothelial
nitric-oxide synthase activation and nitric oxide release from
endothelial cells. J Biol Chem. 282:10660–10699. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shu X, Keller TC IV, Begandt D, Butcher
JT, Biwer L, Keller AS, Columbus L and Isakson BE: Endothelial
nitric oxide synthase in the microcirculation. Cell Mol Life Sci.
72:4561–4575. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kubes P, Suzuki M and Granger DN: Nitric
oxide: An endogenous modulator of leukocyte adhesion. Proc Natl
Acad Sci USA. 88:pp. 4651–5545. 1991; View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qin M, Landriscina A, Rosen JM, Wei G, Kao
S, Olcott W, Agak GW, Paz KB, Bonventre J, Clendaniel A, et al:
Nitric oxide-releasing nanoparticles prevent propionibacterium
acnes-induced inflammation by both clearing the organism and
inhibiting microbial stimulation of the innate immune response. J
Invest Dermatol. 135:2723–2731. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Basile DP: Challenges of targeting
vascular stability in acute kidney injury. Kidney Int. 74:257–258.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Garwood S: Cardiac surgery-associated
acute renal injury: New paradigms and innovative therapies. J
Cardiothorac Vasc Anesth. 24:990–1001. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chade AR, Rodriguez-Porcel M, Grande JP,
Krier JD, Lerman A, Romero JC, Napoli C and Lerman LO: Distinct
renal injury in early atherosclerosis and renovascular disease.
Circulation. 106:1165–1171. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Badal SS and Danesh FR: New insights into
molecular mechanisms of diabetic kidney disease. Am J Kidney Dis.
63 2 Suppl 2:S63–S83. 2014. View Article : Google Scholar : PubMed/NCBI
|
